Heterozygous antithrombin deficiency improves in vivo haemostasis in factor VIII-deficient mice

Thrombosis and Haemostasis

Volumn 103, Issue 6, 2010, Pages 1233-1238

  Bolliger, Daniel ^a,b   Szlam, Fania ^a   Suzuki, Nobuaki ^c   Matsushita, Tadashi ^c   Tanaka, Kenichi A ^a  

^a EMORY UNIVERSITY HOSPITAL   (United States)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antithrombin; Coagulation factors; Haemophilia; Thrombin generation

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 8; THROMBIN; HEMOGLOBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTITHROMBIN DEFICIENCY; ARTICLE; BLEEDING TENDENCY; CONTROLLED STUDY; FEMALE; HEMOPHILIA A; HEMOSTASIS; HETEROZYGOTE; MALE; MOUSE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; ANIMAL; BLEEDING; BLOOD; C57BL MOUSE; CELL CULTURE; DISEASE MODEL; ERYTHROCYTE; GENETICS; GENOTYPE; HUMAN; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; SECRETION (PROCESS);

ANIMALS; ANTITHROMBINS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ERYTHROCYTES; FACTOR VIII; GENOTYPE; HEMOGLOBINS; HEMOPHILIA A; HEMORRHAGE; HETEROZYGOTE; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PARTIAL THROMBOPLASTIN TIME; THROMBIN;

EID: 77953158260     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH09-10-0732     Document Type: Article

References (40)

1. Tanaka KA, Key NS, Levy JH. Blood coagulation: hemostasis and thrombin regulation. Anesth Analg 2009; 108: 1433-1446.
2. Baugh RJ, Broze GJ, Jr., Krishnaswamy S. Regulation of extrinsic pathway factor Xa formation by tissue factor pathway inhibitor. J Biol Chem 1998; 273: 4378-4386.
3. Lu G, Broze GJ, Jr., Krishnaswamy S. Formation of factors IXa and Xa by the extrinsic pathway: differential regulation by tissue factor pathway inhibitor and antithrombin III. J Biol Chem 2004; 279: 17241-17249.
4. Jesty J, Beltrami E. Positive feedbacks of coagulation: their role in threshold regulation. Arterioscler Thromb Vasc Biol 2005; 25: 2463-2469.
5. Mackman N. The role of tissue factor and factor VIIa in hemostasis. Anesth Analg 2009; 108: 1447-1452.
6. Wolberg AS, Allen GA, Monroe DM, et al. High dose factor VIIa improves clot structure and stability in a model of haemophilia B. Br J Haematol 2005; 131: 645-655.
7. Szlam F, Taketomi T, Sheppard CA, et al. Antithrombin affects hemostatic response to recombinant activated factor VII in factor VIII deficient plasma. Anesth Analg 2008; 106: 719-724.
8. Bolliger D, Szlam F, Molinaro RJ, et al. Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: an in vitro model. Br J Anaesth 2009; 102: 793-799.
9. Cvirn G, Gallistl S, Leschnik B, et al. Low tissue factor pathway inhibitor (TFPI) together with low antithrombin allows sufficient thrombin generation in neonates. J Thromb Haemost 2003; 1: 263-268.
10. Fritsch P, Cvirn G, Cimenti C, et al. Thrombin generation in factor VIII-depleted neonatal plasma: nearly normal because of physiologically low antithrombin and tissue factor pathway inhibitor. J Thromb Haemost 2006; 4: 1071-1077.
11. Bi L, Sarkar R, Naas T, et al. Further characterization of factor VIII-deficient mice created by gene targeting: RNA and protein studies. Blood 1996; 88: 3446-3450. (Pubitemid 26365578)
12. Ishiguro K, Kojima T, Kadomatsu K, et al. Complete antithrombin deficiency in mice results in embryonic lethality. J Clin Invest 2000; 106: 873-878.
13. Sambrano GR, Weiss EJ, Zheng YW, et al. Role of thrombin signalling in platelets in haemostasis and thrombosis. Nature 2001; 413: 74-78.
14. Hemker HC, Giesen P, Al Dieri R, et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33: 4-15.
15. Tanaka KA, Szlam F, Vinten-Johansen J, et al. Effects of antithrombin and heparin cofactor II levels on anticoagulation with Intimatan. Thromb Haemost 2005; 94: 808-813.
16. Meeks SL, Healey JF, Parker ET, et al. Non-classical anti-factor VIII C2 domain antibodies are pathogenic in a murine in vivo bleeding model. J Thromb Haemost 2009; 7: 658-664.
17. Ovlisen K, Kristensen AT, Valentino LA, et al. Hemostatic effect of recombinant factor VIIa, NN1731 and recombinant factor VIII on needle-induced joint bleeding in hemophilia A mice. J Thromb Haemost 2008; 6: 969-975.
18. Schlachterman A, Schuettrumpf J, Liu JH, et al. Factor V Leiden improves in vivo hemostasis in murine hemophilia models. J Thromb Haemost 2005; 3: 2730-2737.
19. Tsakiris DA, Scudder L, Hodivala-Dilke K, et al. Hemostasis in the mouse (Mus musculus): a review. Thromb Haemost 1999; 81: 177-188.
20. De Nanteuil G, Gloanec P, Beguin S, et al. Low molecular weight activated protein C inhibitors as a potential treatment for hemophilic disorders. J Med Chem 2006; 49: 5047-5050.
21. van 't Veer C, Golden NJ, Kalafatis M, et al. An in vitro analysis of the combination of hemophilia A and factor V (LEIDEN). Blood 1997; 90: 3067-3072.
22. Franchini M, Montagnana M, Targher G, et al. Interpatient phenotypic inconsistency in severe congenital hemophilia: a systematic review of the role of inherited thrombophilia. Semin Thromb Hemost 2009; 35: 307-312.
23. van Dijk K, van der Bom JG, Fischer K, et al. Do prothrombotic factors influence clinical phenotype of severe haemophilia? A review of the literature. Thromb Haemost 2004; 92: 305-310.
24. Mosnier LO, Bouma BN. Regulation of fibrinolysis by thrombin activatable fibrinolysis inhibitor, an unstable carboxypeptidase B that unites the pathways of coagulation and fibrinolysis. Arterioscler Thromb Vasc Biol 2006; 26: 2445-2453.
25. Kitchens CS. To bleed or not to bleed? Is that the question for the PTT? J Thromb Haemost 2005; 3: 2607-2611.
26. Mann KG. Thrombin formation. Chest 2003; 124: 4S-10S.
27. Beltran-Miranda CP, Khan A, Jaloma-Cruz AR, et al. Thrombin generation and phenotypic correlation in haemophilia A. Haemophilia 2005; 11: 326-334.
28. Al Dieri R, Peyvandi F, Santagostino E, et al. The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding. Thromb Haemost 2002; 88: 576-582. (Pubitemid 35173997)
29. Hemker HC, Al Dieri R, De Smedt E, et al. Thrombin generation, a function test of the haemostatic-thrombotic system. Thromb Haemost 2006; 96: 553-561.
30. Tanaka KA, Szlam F, Rusconi CP, et al. In-vitro evaluation of anti-factor IXa aptamer on thrombin generation, clotting time, and viscoelastometry. Thromb Haemost 2009; 101: 827-833.
31. Rodgers GM. Role of antithrombin concentrate in treatment of hereditary antithrombin deficiency. An update. Thromb Haemost 2009; 101: 806-812.
32. Kawanaka H, Akahoshi T, Kinjo N, et al. Impact of antithrombin III concentrates on portal vein thrombosis after splenectomy in patients with liver cirrhosis and hypersplenism. Ann Surg 2010; 251: 76-83.
33. Kempton CL, Escobar MA, Roberts HR. Hemophilia care in the 21st century. Clin Adv Hematol Oncol 2004; 2: 733-740.
34. Menache D, Grossman BJ, Jackson CM. Antithrombin III: physiology, deficiency, and replacement therapy. Transfusion 1992; 32: 580-588.
35. Shetty S, Vora S, Kulkarni B, et al. Contribution of natural anticoagulant and fibrinolytic factors in modulating the clinical severity of haemophilia patients. Br J Haematol 2007; 138: 541-544.
36. Schulman S, Eelde A, Holmstrom M, et al. Validation of a composite score for clinical severity of hemophilia. J Thromb Haemost 2008; 6: 1113-1121.
37. Yanada M, Kojima T, Ishiguro K, et al. Impact of antithrombin deficiency in thrombogenesis: lipopolysaccharide and stress-induced thrombus formation in heterozygous antithrombin-deficient mice. Blood 2002; 99: 2455-2458.
38. Rapaport SI, Toneff T, Rimon A, et al. The effect of immunodepletion of antithrombin III on the response of rabbits to Russell's viper venom-induced activation of factor X. Arterioscler Thromb Vasc Biol 1997; 17: 409-416. (Pubitemid 27098201)
39. Broze GJ, Jr., Yin ZF, Lasky N. A tail vein bleeding time model and delayed bleeding in hemophiliac mice. Thromb Haemost 2001; 85: 747-748. (Pubitemid 32293718)
40. Kahn ML, Zheng YW, Huang W, et al. A dual thrombin receptor system for platelet activation. Nature 1998; 394: 690-694.